Silverline Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 130.36%
- Profit Growth 62.40%
- Ebitda 340.09%
- Net Worth 74.88%
- Total Assets -11.78%
About Silverline Medicare
Silverline Medicare Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 November 2015 (Nine years and two months 30 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Kewalramani and Asudaram Kewalramani serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51101MH2015PTC270096
-
Company No.
270096
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Nov 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Silverline Medicare Private Limited offer?
Silverline Medicare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Anaemia Medicine, Eye Drops, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications.
Who are the key members and board of directors at Silverline Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Kewalramani
|
Director | 10-Nov-2015 | Current |
|
Asudaram Kewalramani
|
Director | 10-Nov-2015 | Current |
Financial Performance of Silverline Medicare.
Silverline Medicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 130.36% increase. The company also saw a substantial improvement in profitability, with a 62.4% increase in profit. The company's net worth Soared by an impressive increase of 74.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silverline Medicare?
In 2020, Silverline Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Silverline Medicare?
Unlock and access historical data on people associated with Silverline Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silverline Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silverline Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.